|
Natural
products: Leads for new pharmaceuticals
Advances
in molecular biology and automation technology will allow even greater
number of samples to be tested against more pharmacological targets,
say Ravinder Reddy B, Asif Ansari and Shivkumar
I
The
use of plants for medicinal purposes dates back thousands of years
and even early inhabitants of the earth have been known to chew
certain leaves only when suffering from gastro intestinal disturbances.
Well-known ancient remedies are morphine, codeine, belladona alkaloids
like atropine used as mydriatic and digitalis glycosides used as
cardiac stimulant. In more recent times microbial metabolites have
been utilized in medicine ex; naturally occuring fungal metabolities
cyclosporin and lovastatin used for immunosuppression and to treat
hypocholesterolemia.
Natural
products have also been utilized as chemical models or templates
for the design of synthesis of many other important drugs. Another
opium alkaloid papavarine was used to the synthesis of the open
chain analog, verapamil which is used to treat the cardiovascular
disease and hypertension.
Aspirin
of which 25kg is produced, actually is derived from salicin, a secondary
metabolite produced by the willow tree. The plant steroids diosgenin
and hecogenin remain key precursor for the synthesis of many modern
contraceptive drugs and other useful pharmaceuticals including betamethasone
for the treatment of eczema and psoriasis and beclomethasone for
treating asthma. The abundance of plant and microbial secondary
metabolites and their values in medicine are undisputed.
Mammals
are producing morphine type metabolites and its congeners in their
tissues but a highly regio and stereo selective cytochrome P-450
enzyme has been discovered in pigs liver which is also responsible
for the oxidative coupling of (R) - reticuline to salutaridine and
thus the formation of morphine type metabolites in mammals. The
challenge to medicinal chemist is to exploit this unique chemical
diversity.
Drugs
affecting Central Nervous System
Morphine
Alkaloids: Morphine is a lead molecule which acts as a analgesic
and its derivatives like codeine used for treatment of moderate
pain, a semi-synthetic derivative heroin used in terminal cancer,
where its addictiveness is irrelevant. Actylation masks the polar
hydroxyl groups, so that generation into CNS is enhanced. Modification
of C ring of morphine are legion, but none of the derivatives
are free from addictive liability. N-demethylation, re-alkylation
gives more interesting analogs, which is a morphine antagonist,
some more drugs are developed by morphine lead like naloxone, benzomorphans,
buprenorphine, thebaine, etc.
Cannabinoids:
Cannabis sativa, which possesses cannabinol which has sedation effect,
CNS effects cardiovascular effects (tachycardia, postural hypotension).
The measured dose of Cannabinol dissolved in sesame oil and administered
in gelatin capsule. The multiplicity of effects of cannabinol have
led to the synthesis of large number of analogs, particularly non-morphine,
like analgesics without addictiveness and without the other CNS
effects of cannabinol. Nabilone, a derivative of cannabil, is formed
to be less effective on cardiovascular system than cannabinol, while
retaining the mixture of CNS actions, including analgesics, antianxiety
and antipsychotic properties. When testing as an antiemetric nabilone
proved to be superior to cannabinol.
The
recent cannabinol receptor is anandamine, a little obvious
structural similarity between cannabinol and anandamide, opening
up new areas for research into analogs of the latter which may achieve
the ultimate goal of separation of all the mixed effects of cannabinol.
Without cannabinol, nobody would have looked for the endogenous
ligand.
Asperlicin:
Asperlicin is moderately potent poorly soluble in water and not
bio-available by the oral route. It was an interesting target for
synthetic modification. Particularly viewed as a benzodizepine derivative
with potential CNS activity.
Neuro
muscular blocking drugs: Curare, decamethonium and atracurium
are obtained from plants and their derivatives are synthesised like
tubocurarine, metocurine, C-toxiferine-I, alcuronium, laudexium,
mivacurium etc.
Anti-cancer
drugs: Catharanthus roseuse, which possess around 55 alkaloids
is pharmacological interest. Vinblastine used in Hodgkins
disease and metastatic testicular tumour, where as Vincristine is
used for the treatment of lymphocytic leukaemia in children.
Taxol
and Taxotere, obtained from Taxus baccata and Taxus brevifolia respectively
are used for treatment of leukaemia. The derivatives available are
baccatin II, 10-desacetyl bacctin III, phenyl isoserine.
Podophyllotoxin,
etoposide and Teniposide are obtained from Podophyllum Peltatum
P.emodi and inhibits cell proliferation by binding to tubulin and
preventing formation of microtubules.
Antibiotics:
B lactum antibiotics are produced from Penicillium chrysogenum which
possess 6-APA nucleus use full for development of new antibiotics.
Clavulanic
acid, isolated from Streptomyceclavuligerus, which is a potential
inhibitor of B lactamases is useful for development of new antibiotics.
Streptomycin,
aminoglycosides which is isolated from Streptomyces griseus in a
potent antibiotic,
useful for development of new therapeutics.
Cephalosporins
are isolated from fungus called cephalosporium acremonium, which
acts as antibiotics.
Thienamycin,
isolated from streptomyes cattleya which is a potent antibiotic.
Psuedomonas acidophila, Chromobacterium violacium are also produce
B lactam antibiotics.
Erythromycin,
isolated from saccharopolyspora erythraea, which is a broad spectrum
antibiotic. The derivative of erythromycin are roxithromcyin, clacithromycin,
dithromycin, azithromycin.
Echinocandin
B, which is produced by Asperigillus nidulans, acts as potent antibiotic:
Cardiovascular
drugs: Lovastatin, simvastatin and pravastatin are inhibits
enzymes. The similar compounds are isolated from Pencillium citrinum
and possess same action. Development of these compounds are done
for the treatment drug ML-236B.
Teprotide
and Captopril are the specific compounds in the venom of pitviper
Bothops jararaca, which acts as ACE inhibitors.
Khellin
is isolated from Ammi vishanaga which possesses antiasthama effect.
Antiparasitic
drugs: Artimisinin, artemether and arteether are isolated for
artemisia annua which posses antiparasitic activity, the active
constituents obtained from Cinchona succirubra (quinine, chloroquine
mefloquine) posses antimalarial activity.
Conclusion
Natural
product samples represent a rich chemical diversity which will continue
to be an important source of lead compounds for medicinal chemistry
programs and will also provide biochemical tools for mechanistic
studies. Advances in molecular biology and automation technology
will allow even greater number of samples to tested against more
pharmacological targets. This fact, coupled with the knowledge that
perhaps over 90 per cent of bacteria, fungal and plants species
are still waiting to be investigated, means that medicinal chemist
has a unique opportunity to continue utilizing the rich chemical
diversity offered by the nature.
The
writers are with SCS College of Pharmacy, Davanageri, Karnataka
|